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Abstract
Background: Based on moderate quality evidence, routine pelvic examination is strongly recommended against in
asymptomatic women. The aims of this study was to quantify the extent of routine pelvic examinations within specialized
health care in Norway, to assess if the use of these services differs across hospital referral regions and to assess if the use
of colposcopy and ultrasound differs with gynecologists’ payment models.
Methods: Nationwide cross-sectional study including all women aged 18 years and older in Norway in the years 2014–16
(2,038,747). Data was extracted from the Norwegian Patient Registry and Statistics Norway. The main outcome measures
were 1. The number of appointments per 1000 women with a primary diagnosis of “Encounter for gynecological
examination without complaint, suspected or reported diagnosis.” 2. The age-standardized number of these
appointments per 1000 women in the 21 different hospital referral regions of Norway. 3. The use of colposcopy and
ultrasound in routine pelvic examinations, provided by gynecologists with fixed salaries and gynecologists paid by a
fee-for-service model.
Results: Annually 22.2 out of every 1000 women in Norway had a routine pelvic examination, with variation across regions
from 6.6 to 43.9 per 1000. Gynecologists with fixed salaries performed colposcopy in 1.6% and ultrasound in 74.5% of
appointments. Corresponding numbers for fee-for-service gynecologists were 49.2% and 96.2%, respectively.
Conclusions: Routine pelvic examinations are widely performed in Norway. The variation across regions is extensive.
Our results strongly indicate that fee-for-service payments for gynecologists skyrocket the use of colposcopy and increase
the use of ultrasound in pelvic examinations of asymptomatic women.
Keywords: Routine pelvic examination, Unwarranted examination, Fee-for-service, Regional variation, Ultrasonography,
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Background
Based on moderate quality evidence, routine pelvic
examination is strongly recommended against in asymp-
tomatic women [1–3], as is screening colposcopy [4] and
routine screening for ovarian cancer in asymptomatic
women [5–7]. In the Prostate, Lung, Colorectal and
Ovarian Cancer Screening Randomized Controlled Trial,
including 78,000 women, bimanual examination of the
ovaries was discontinued as no ovarian cancer was
detected merely by palpation [8]. Use of screening CA
125 and transvaginal ultrasound does not reduce ovarian
cancer mortality [8, 9] and is advised against [5, 10].
High rates of colposcopy do not decrease cervical cancer
incidence or mortality [11]. False positive screening test
results are associated with harm. Women screened for
ovarian cancer have a 33% increased risk of oophorec-
tomy [8] and for every screening detected cancer ten
women undergo surgery following a false positive ultra-
sound examination [9]. Ultrasound of the pelvis should
not be performed unless clear indications are present
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[12]. Pelvic examination prior to provision of hormonal
contraceptives does not identify women who should
avoid these contraceptives and is not recommended as
routine practice [13].
The Norwegian public health system is well developed
with access for all inhabitants. All citizens have a legal
right to equal access to good quality health care [14]. All
citizens are entitled to a regular general practitioner
who, if necessary, refers the patient to specialized care.
Apart from abortions, women themselves cannot make
an appointment at a publicly reimbursed gynecologist
without a referral.
The municipalities of Norway are allocated into 21 dif-
ferent hospital referral regions. Each region has a defined
health enterprise responsible for providing specialized
health care for their inhabitants. The health enterprises
collaborate with private physicians to varying degrees. In
Norway all gynecologists at public hospitals are paid a
fixed salary, while a fee-for-service model pays private
gynecologists that collaborate with the health enterprises.
Methods
Aims
1. To quantify the extent of routine pelvic
examinations within specialized health care in
Norway.
2. To assess if the use of these services differs across
hospital referral regions.
3. To assess if the use of colposcopy and ultrasound
differs with gynecologists’ payment models.
Study design
Nationwide cross-sectional study on routine pelvic
examinations within specialized health care in Norway.
Setting
The Norwegian Patient Registry (NPR) contains health
reports on every appointment within publicly funded
specialized health care in Norway. Both public hospi-
tals and private gynecologists that collaborate with the
health enterprises report diagnoses of every patient
appointment to NPR. The appointments are linked to
the patients through the personal identification num-
ber of all inhabitants of Norway. Data from NPR is
used for central planning of specialized health care,
activity based financing, quality indicators, and health
care research. Through Centre for Clinical Documen-
tation and Evaluation (SKDE) we had access to reports
for 2014–16 in addition to annual population statistics
from Statistic Norway. One author (LL) had access to
indirect personally identifiable data from NPR. All
analyses and results are anonymous.
Participants
We included all Norwegian women aged 18 years and
older in Norway in the years 2014–16 (n = 2,038,747).
Variables and data sources
In this study private gynecologists who get public reim-
bursement are for simplicity called “fee-for-service gyne-
cologists.” The term “fixed salary gynecologists” is used
for gynecologists working in public hospitals, as the sal-
aries of these gynecologists are independent of quantity
of care. Data from privately out-of-pocket paid gynecolo-
gists’ practice is not included in the study as such data is
not recorded in Norway.
Both fixed salary and fee-for-service gynecologists
used the International Classification of Diseases version
10 (ICD-10) for reports to NPR. The Norwegian versions
for 2014–16 were in use during the study years. The
three versions are identical for the codes we have stud-
ied [15]. All gynecologists also reported the municipality
and city district code for the patients’ residency. We
used these codes to allocate appointments to the differ-
ent hospital referral regions.
We defined routine pelvic examination as a primary
diagnosis of ICD-10 Z01.4; “Encounter for gynecological
examination without complaint, suspected or reported
diagnosis.” Cervical screening was defined as a primary
diagnosis of the ICD-10 code Z12.4; “Encounter for
screening for malignant neoplasm of cervix.”
For hospital appointments colposcopy was defined by
the allocation of the code LXE00 (colposcopy) in the
2014–16 versions of The NOMESCO Classification of
Surgical Procedures (NCSP) [16]. Ultrasound was defined
by the allocation of any of the codes LXDE05 (transvaginal
ultrasound), SLXOBK or SLXOAK (transvaginal ultra-
sound of female pelvic organs) in the 2014–16 versions of
the Norwegian Classification of Medical Procedures
(NCMP) and the Norwegian Classification of Radiological
Procedures (NCRP) [16]. For fee-for-service gynecologists
colposcopy and ultrasound were defined either by the same
procedure codes or by the allocation of the codes 208 (col-
poscopy) and 211c (transvaginal ultrasound) in “Tariff for
publicly funded private physicians” versions 2014–16 [17].
In addition “complete examination” at a fee-for-service
gynecologist was defined by the allocation of the tariff code
4b1 (allowance for complete examination performed by a
specialist (after referral)).
Both publicly funded hospitals and fee-for-service gyne-
cologists that get public funding are obligated to report
surgical, medical, and radiological procedures according to
NCSP, NCMP, and NCRP to NPR. In addition, fee-for-
service gynecologists include tariff codes from “Tariff for
publicly funded private physicians” in the reports sent to
NPR. For each individual tariff code they report they get
extra reimbursement. It is known that some fee-for-service
Rosenlund et al. BMC Women's Health  (2017) 17:114 Page 2 of 8
physicians underreport NCSP and NCMP codes. There-
fore we also included the more thoroughly reported tariff
codes to the definition of colposcopy and ultrasound for
fee-for-service gynecologists.
Statistical analysis
We obtained the age-standardized number of appoint-
ments for routine pelvic examination per 1000 women
in Norway, and for the 21 different hospital referral
regions. We also quantified the use of colposcopy and
ultrasound in appointments for routine pelvic examin-
ation for women examined by gynecologists with fixed
salaries and fee-for-service gynecologists, respectively.
Differences between provider types were compared with
Pearson’s chi-square test. For fee-for-service gynecolo-
gists the number of appointments with codes for “Allow-
ance for complete examination performed by a specialist
(after referral)” was also examined. All numbers reported
are the annual mean for 2014–16, unless otherwise
stated.
There were missing data for municipality code in 0.5%
(215) of appointments annually. As it is likely that
patients do not travel far for routine pelvic examina-
tions, we analyzed these appointments according to the
referral region where the examination took place.
In additional analyses, we quantified the extent of
cervical screening tests within specialized health care in
Norway, and we examined if differences across hospital
referral regions in routine pelvic examinations were
depended on differences in cervical screening tests. We
also examined if the use of colposcopy and ultrasound,
and variation across regions in pelvic examinations were
depended on registered secondary diagnosis.
We used SAS Enterprise Guide 7.1 [18] to analyze
the data.
Patient involvement
Patients were not formally involved in the planning or
conduction of the study. However, the subject under
investigation involves all Norwegian adult women
including the female authors of this paper.
Results
The estimated adult female population of Norway in the
years 2014–16 was 2,038,747. Nationally there were 22.2
pelvic examinations per 1000 women (Table 1). Of
women who received a pelvic examination during the
years of investigation, the majority (88.9%) had only one
exam. The number of appointments per patient was 1.04
annually and 1.14 during the 3 year period.
Women aged 25–69 years constituted 87.6% (39,589)
of appointments. Annually, 2.6% (38,065) of women aged
25–69 years had a routine pelvic examination, while
0.97% (2231) of younger women and 0.96% (3143) of
those aged 70 years or older were examined (Fig. 1).
Pelvic examinations per 1000 women ranged from 6.6
to 43.9 across hospital referral regions (Fig. 2). Fee-for-
service gynecologists performed two thirds (29,324) of
pelvic examinations with the mean age of women exam-
ined being 1.1 years higher than at fixed salary gynecolo-
gists (47.8 vs. 46.7 years). Colposcopy was used in 1.6%
(249) and ultrasound in 74.5% (11,810) of appointments
at fixed salary gynecologists, while fee-for-service gyne-
cologists used colposcopy in 49.2% (14,427) and ultra-
sound in 96.2% (28,216) of appointments (Fig. 3).
Differences in use of colposcopy (p < .001) and ultra-
sound (p < .001) between provider types were statistical
significant.
In addition 87.3% (29,324) of appointments in private
practice had a procedural code for “complete examin-
ation performed by a specialist.”
Additional analysis showed that there were 2013
appointments within publicly funded specialized health
care for cervical screening appointments annually. Cervical
screening constituted 4.3% of the combined number of
appointments for cervical screening and routine pelvic
examinations. The use of ultrasound was equivalent in
appointments for cervical screening and routine pelvic ex-
aminations (91.3 vs. 88.6%). Both fixed salary and fee-for-
service gynecologists used colposcopy more frequently in
appointments for cervical screening compared to routine
pelvic examinations. Fixed salary gynecologists used
colposcopy in 9.8% (13) of cervical screening appointments
(routine pelvic examination: 1.2%). The corresponding
number fee-for-service gynecologists was 69.8% (1310)
(routine pelvic examination: 49.2%). Fee-for-service gyne-
cologists performed 93.3% (1877) of cervical screening
examinations. Out of these 87.4% (1641) had a reimburse-
ment code for “complete examination performed by a spe-
cialist.” Adding cervical screening appointments to the
analysis of regional variation caused minor sequence
replacements for three regions while the national extent of
variation did not change (Additional file 1).
In 16.5% (7472) of appointments one or more secondary
diagnoses were registered. During the 3 year period there
were 856 different secondary diagnoses from almost all
Table 1 Appointments for routine pelvic examinations in Norway,
2014–16
Measures 2014 2015 2016 Annual mean
2014–16
Patients, n 44,731 41,941 43,644 43,439
Appointments, n 46,619 43,534 45,382 45,178
Appointments per
1000 women
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chapters in ICD-10. The variation in use of colposcopy
and ultrasound between appointments with and without
secondary diagnoses was minimal compared to the differ-
ences between fixed salary and fee-for-service gynecolo-
gists (Table 2).
Excluding appointments with secondary diagnoses in
the analysis of regional variation caused minimal
sequence replacements of five regions (Additional file 2).
Discussion
Principal findings
Routine pelvic examinations are widespread in Norway.
Annually, 22.2 per 1000 adult women received a pelvic
examination that is recommended against. The variation
across hospital referral regions was extensive and ranged
from 6.6 to 43.9 per 1000 women. Gynecologists with fixed
salaries performed colposcopy in 1.6% and ultrasound in
74.5% of appointments, while fee-for-service gynecologists
performed colposcopy in 49.2% and ultrasound in 96.2% of
appointments. Fee-for-service payments for gynecologists
seem to drive the utilization of colposcopy and ultrasound
in routine pelvic examinations.
Interpretation
This is the first study to document the widespread use
of unwarranted routine pelvic examinations in Norway.
The great majority of examinations were performed on
women aged 25–69 years. The Norwegian Cervical























Fig. 1 Number per 1000 women receiving routine pelvic examinations by age groups. Annual mean for the years 2014–16
Fig. 2 Age-standardized number of appointments for routine pelvic examination per 1000 women by hospital referral region and type of provider
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Cancer Screening Programme recommends and reminds
all women between the age of 25 and 69 years to have a
cytology test done every 3 years [19]. The correlation
between cervix screening age and the age distribution in
this study indicates that a large proportion of women
with a routine pelvic examination may have had the
extended examination as part of cervix screening. The
number of appointments for each woman was 1.14 dur-
ing the 3 years study period, which further strengthens
this interpretation.
The real extent of routine pelvic examination in special-
ized health care seems to be higher than our study reveals,
as the content of health care delivered in cervical screening
appointments is equivalent to what is demonstrated in
routine pelvic examinations. Pelvic examination, pelvic
ultrasound and colposcopy are not indicated in asymptom-
atic women and are not part of The Norwegian Cervical
Cancer Screening Programme, unless the result of the
cytology test shows cause for concern [19]. There are
separate ICD-10 codes for abnormal cervical cytological
findings [15]. If women in our study actually were referred
to specialized health care for routine testing within The
Norwegian Cervical Cancer Screening Programme, our re-
sults demonstrate overuse of specialist health care services
as cervical screening is supposed to be a primary care
undertaking. This reflects a recently observed shift from
primary to specialized health care for insertion of intra-
uterine contraception [20]. The finding of high numbers of
colposcopy, ultrasound, and “complete examinations” in
cervical screening appointments adds to this overuse.
Based on our findings, we argue that primary care physi-
cians should perform cervix screening.
Concomitant cervix screening cannot explain the
extensive regional variation observed. Neither can differ-
ences in morbidity across the regions, as the women
examined were by definition healthy. Geographical vari-
ation is shown to be associated with supply sensitive
care [21]. The extent of variation in the present study
points to examinations that are dependent on local
health care practice and supply.
While the American College of Physicians, the Canad-
ian Task Force on Preventive Health Care and the
American Academy of Family Physicians strongly rec-
ommend against routine pelvic screening examinations,
the debate is not settled. The US Preventive Services
Task Force Recommendation Statement concludes “that
the current evidence is insufficient to assess the balance
of benefits and harms of performing screening pelvic
examinations” [22]. The American Congress of Obstetri-
cians and Gynecologists reaffirmed in 2016 their Com-
mittee Opinion which purpose is “to explain the need
for annual assessments” albeit “at this time, this recom-
mendation is based on expert opinion” [23].
The academic ambiguity concerning routine pelvic
examinations might be reflected in our findings of exten-






































Fig. 3 Proportion (%) of appointments with colposcopy and ultrasound in routine pelvic examinations by comparison of fixed salary and
fee-for-service gynecologists
Table 2 Colposcopy and ultrasound in routine pelvic
examinations by comparison of payment model and whether or
not the appointment had a registered secondary diagnosis.
Annual mean for the years 2014–16
Fixed salary gynecologist Fee-for-service
gynecologist

























Rosenlund et al. BMC Women's Health  (2017) 17:114 Page 5 of 8
a referral, the regional variation might be explained by
regional differences in referral pattern. However our
study cannot answer if the observed variation is due to
regional differences in: supply (i.e. the number of gynecol-
ogists to refer to); professional belief in and tradition for
routine examinations; or the proportion of examinations
performed by primary care physicians and gynecologists,
respectively.
Either way, there is no pelvic screening program in
Norway. Both the extensive regional variation and the
extent of routine pelvic examinations per se are unwar-
ranted in regard to the Norwegian Patients’ Rights Act
[14] and in regard to the Norwegian Medical Associa-
tions concerns on opportunistic screening [24].
Health expenditures are increasing worldwide and
account for more than 12% of gross domestic product in
OECD countries [25]. Apart from Luxembourg, no coun-
try spends more on publicly financed health care per capita
than Norway [26]. It is recognized that fee-for-service
reimbursement is the most important driver of high med-
ical expenditures in the United States [27]. Fee-for-service
in primary care has been reported to be associated with
more visits, diagnostic tests and referrals compared to
salary payment, though evidence is limited [28]. Ransom et
al. have demonstrated that elective gynecological proce-
dures are performed more frequently under fee-for-service
than capitation payment [29]. The present study supports
these findings as fee-for-service gynecologists used colpos-
copy and ultrasound 31.2 and 1.3 times more often than
gynecologists with fixed salaries, respectively. Fee-for-
service gynecologists have an economic incentive to
extend the examination not only through the tariff for
colposcopy and ultrasound, but also through reimburse-
ment for “complete examination.” This code was used in
87.3% of fee-for service appointments.
Theoretically, patient preferences might explain some
of the differences between provider types and also the
regional differences. However there is no evidence that
patient preferences have much impact on regional vari-
ation [30]. It is highly unlikely that healthy women
referred to fixed salary physicians opt out colposcopy
while the majority of women examined by fee-for-
service gynecologists actively want this procedure. More-
over colposcopy and ultrasound are advised against in
the screening setting, and should not be an offer within
publicly funded healthcare regardless of preferences.
Our results strongly imply that fee-for-service payments
for gynecologists skyrocket the use of colposcopy and
drive the use of “complete examinations” and ultrasound
in pelvic examinations of asymptomatic women.
Recalibrating fee-for-service payments is recommended
as one measure to constrain unsustainable health care
expenditures [27]. Based on our findings, we argue that
reimbursements for routine pelvic examinations including
complete examination, colposcopy and ultrasound in
women not registered with any symptom, complain or
diagnosis should be discontinued. If gynecologists perform
cytology screening in healthy women, any extra reimburse-
ment should be removed.
Generalizability
To our knowledge, no other studies have quantified the
national extent of routine pelvic examinations within
publicly funded specialized health care. In Norway there
has never been a national guideline recommending
pelvic examination in asymptomatic women, nor a
screening program for ovarian cancer. “Well-woman
visits” [23] are not advocated by any Norwegian health
authorities and the majority of women are unfamiliar
with the practice. It is reasonable to believe that Norway
scores relatively low on the number of routine pelvic ex-
aminations compared to countries with traditions and
recommendation for annual assessments, and countries
with a higher degree of fee-for-service-reimbursements
for gynecologists.
This study only quantifies the use of pelvic examinations
within publicly funded specialized health care. Private
gynecologists with public funding constitute 43.5% of all
private gynecologists in Norway [31]. The remainders are
privately paid. The number of routine pelvic examinations
paid out-of-pocket is unknown, as is the number
performed by primary physicians. There is no reason to
believe that privately paid gynecologists perform routine
pelvic examinations any less than publicly funded gynecol-
ogists. On the contrary, privately paid gynecologists com-
monly advertise for routine pelvic examinations, hence, we
believe that our study substantially underestimates the total
amount of unwarranted pelvic examinations in Norway.
Strengths and limitations
The major strength of the study is the inclusion of all
Norwegian adult women and that the studied codes give
the basis for actual reimbursements paid to hospitals
and fee-for-service gynecologists. Registration and
reporting of appointments is compulsory and economic-
ally important for both hospitals and fee-for-service gy-
necologists. Correct reporting is focused on and stressed
in both settings.
There are several limitations inherent in the method-
ology of register studies. Code practice may vary across
regions. Underreporting of secondary diagnosis is expected
[32]. Fee-for-service gynecologists get reimbursement
according to the procedures they perform, while fixed sal-
ary gynecologists neither get compensated personally nor
get more reimbursements to the hospital by performing
colposcopy or ultrasound in routine pelvic examinations.
Hence, it is possible that fee-for-service gynecologists are
more thorough in their reporting, and that the actual use
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of colposcopy and ultrasound especially in hospitals is
underreported. Still, it is highly unlikely that this can
explain the huge differences observed.
Conclusions
Annually, 22.2 per 1000 adult women in Norway received
a publicly funded pelvic examination that is recommended
against. The variation across regions was extensive. Our
results strongly indicate that fee-for-service payments for
gynecologists skyrocket the use of colposcopy and
increase the use of ultrasound in routine pelvic examina-
tions. We argue that the reimbursement for these exami-
nations should be discontinued, not only as a measure to
constrain the unsustainable growth in health care expen-
ditures, but also for the wellbeing of healthy women.
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